Italian Stem Cell Controversy

Italian government officials and scientists clashed last week with a controversial stem cell researcher over details of an upcoming clinical trial.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Palazzo Montecitorio is home to one house of the Italian Parliament.WIKIMEDIA COMMONS, RUANDABIT

A panel of Italian science administrators and stem cell scientists convened Friday (July 12) to discuss with Davide Vannoni, the president of the Stamina Foundation, the details of a government-sponsored clinical trial of a controversial stem cell treatment, reported ScienceInsider.

Italian stem cell scientists have criticized Stamina’s treatment as being untested, and opponents of the trial are hoping that recent news concerning allegedly plagiarized figures in a patent application filed by Vannoni will steer public funds away from the research. One critic, Massimo Dominici, president-elect of the International Society for Cellular Therapy, told ScienceInsider that the proposed trial is a “waste of money.”

Despite the scrutiny, the Italian Parliament decided in May that a small group of patients could continue treatment, and has set aside ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies